<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="39949" whole_study_id="39949" phs="002295" v="1" p="1" createDate="2020-11-20T00:55:44-05:00" completedByGPADate="2020-11-20T01:15:43-05:00" modDate="2021-03-11T22:22:18-05:00" maxParentChildStudyModDate="2021-03-11T22:22:18-05:00" handle="CIMAC_CIDC_SeqConcordance" num_participants="8"><StudyInfo accession="phs002295.v1.p1" parentAccession="phs002295.v1.p1"><BioProject id="PRJNA679858" entrez_id="679858" type="bp_admin_access"/><BioProject id="PRJNA679859" entrez_id="679859" type="bp_data_submission"/><StudyNameEntrez>Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms of CIMAC-CIDC network</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="whole_targ_exome"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/><StudyType22 name="tumor_normal"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>germline</StudyType><StudyType>tumor_normal</StudyType><StudyType>whole_exome</StudyType><StudyType>whole_transcriptome</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="CWU001" aid="2" auth="eRA" login="CWU001" fname="Catherine" mname="JU-YING" lname="Wu" email="cwu@partners.org"><Role allow_direct_access="true">PI</Role><Organization>DANA-FARBER CANCER INST</Organization></Person><Person nedid="0011061339" aid="1" auth="cit" login="thurinm" fname="Magdalena" mname="" lname="Thurin" email="mt244h@nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="ZEXIANZENG" aid="2" auth="eRA" login="ZEXIANZENG" fname="Zexian" mname="" lname="Zeng" email="Zexian_Zeng@DFCI.HARVARD.EDU"><Role>PI_ASSIST</Role><Organization>DANA-FARBER CANCER INSTNORTHWESTERN UNIVERSITY AT CHICAGO</Organization></Person><Person nedid="2002777465" aid="1" auth="cit" login="wuz8" fname="Zhuoxi" mname="" lname="Wu" email="joe.wu@nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2002647128" aid="1" auth="cit" login="guptan11" fname="Neha" mname="" lname="Gupta" email="neha.gupta2@nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014159529" aid="1" auth="cit" login="waltont" fname="Tamara" mname="Bene" lname="Walton" email="waltont@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Scientific and financial supports for the CIMAC-CIDC Network are provided through the National Cancer Institute (NCI) Cooperative Agreements U24CA224319 (to the Icahn School of Medicine at Mount Sinai CIMAC), U24CA224331 (to the Dana-Farber Cancer Institute CIMAC), U24CA224285 (to the University of Texas MD Anderson Cancer Center CIMAC), U24CA224309 (to the Stanford University CIMAC), and U24CA224316 (to the CIDC at Dana-Farber Cancer Institute).  This work is also supported by grants from the Lung SPORE P50CA070907, NIH CCSG Award (CA016672), MD Anderson Cancer Center Support Grant (CA016672), National Cancer Institute under contract HHSN261200800001E. Additional support is made possible through the NCI CTIMS Contract HHSN261201600002C (to the Emmes Company, LLC).  Scientific and financial supports for the PACT projects are made possible through funding support provided to the FNIH by: AbbVie Inc., Amgen Inc., Boehringer-Ingelheim Pharma GmbH &amp; Co. KG., Bristol-Myers Squibb, Celgene Corporation, Genentech Inc, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Novartis Institutes for Biomedical Research, Pfizer Inc., and Sanofi. </acknowledgement_statement><ic_specific_access_term>Genomic summary results will be available only to CIMAC-CIDC network investigators, trial Principal Investigators and approved personnel as described by the CIMAC-CIDC guidelines (https://cimac-network.org/wp-content/uploads/2019/08/Guidelines-for-CIMAC-CIDC-Aug-20-2019.pdf)</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="4258" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="4258"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>